Cell & Gene Therapy Manufacturing and Commercialization

Cell & Gene Therapy Manufacturing and Commercialization is a conference that covers topics such as:

• Cell and Gene Therapy Bioprocessing
  • Get to grips with technologies and novel platforms for efficient upstream and downstream processes
  • Build a strategy for monitoring quality across your process with PAT and automated analytics
  • Simplify manufacturing automation and prepare for commercialization
• Clinical and Early Stage CAR T Cell and Gene Therapy Advances
  • Transition technologies from bench to bedside: CRISPR, Exosomes and more.
  • Push the boundaries of CD19 with solid tumours, combination therapies and safety switches
  • Understand how to build a sustainable process early on for optimum clinical translation
• Supply Chain Barriers: Upstream and Downstream Considerations
  • Stay up to date on cryo considerations when moving from clinical to commercial phase manufacturing
  • Improve confidence in your raw material supply chain - vectors, risk mitigation and more
  • Prepare for successful delivery to patients & supply chain scale up
• Cell & Gene Therapy Commercialization
  • Optimise the way you work with external partners to drive commercialization
  • Work towards industry 4.0 - integrating manufacturing and delivery into healthcare
  • Ensure profitability with forward thinking in facility design and scalability strategies
• Bio fabrication - The Path to Commercialization: With ARMI
  • Stay tuned for more updates soon
  • In collaboration with our event partners ARMI (Advanced Regenerative Manufacturing Institute) we will be bringing you an exciting day jam packed with content on making practical the large-scale manufacturing of engineered tissues and tissue-related technologies, to benefit existing industries and grow new ones
• Cell and Gene Therapy Connect - Partnering Track
  • Tackle collaboration - new outsourcing models, when to make the decision to `spin out` and more
  • Keep abreast of the evolving landscape of cell and gene therapies
  • Dive into pharmacoeconomic approaches to reimbursement